Additional file 1 of Low high-density lipoprotein and increased risk of several cancers: 2 population-based cohort studies including 116,728 individuals
Creators: name: Pedersen, Kasper Mønsted
name: Çolak, Yunus
name: Bojesen, Stig Egil
name: Nordestgaard, Børge Grønne
Publisher: name: figshare
Year: 2020
Subjects: subject: Biochemistry
subject: Medicine
subject: Biotechnology
subject: 59999 Environmental Sciences not elsewhere classified
subject: FOS: Earth and related environmental sciences
subject: FOS: Earth and related environmental sciences
subject: Ecology
subject: FOS: Biological sciences
subject: FOS: Biological sciences
subject: Developmental Biology
subject: Plant Biology

description: Additional file 1: Table S1. Baseline characteristics of individuals in the Copenhagen General Population Study according to HDL cholesterol levels. Table S2. Baseline characteristics of individuals in the Copenhagen General Population Study according to apolipoprotein A1 levels. Table S3. Baseline characteristics of individuals in the Copenhagen City Heart Study according to HDL cholesterol levels. Table S4. Baseline characteristics of individuals in the Copenhagen City Heart Study according to apolipoprotein A1 levels. Figure S1. Association of HDL cholesterol levels with risk of gynecological, urological, gastrointestinal, prostate, malignant melanoma, and other cancer in individuals from the Copenhagen General Population Study. Figure S2. Association of apolipoprotein A1 levels with risk of gynecological, urological, gastrointestinal, prostate, malignant melanoma, and other cancer in individuals from the Copenhagen General Population Study. Figure S3a and S3b. Association of HDL cholesterol levels with risk of 27 specific cancer types in individuals from the Copenhagen General Population Study. Figure S4a and S4b. Association of apolipoprotein A1 levels with risk of 27 specific cancer types in individuals from the Copenhagen General Population Study. Figure S5. Association of HDL cholesterol and apolipoprotein A1 levels with risk of hematological, breast, and respiratory cancer in individuals from the Copenhagen City Heart Study. Figure S6. Association of HDL cholesterol and apolipoprotein A1 levels with risk of any cancer in individuals from the Copenhagen General Population Study according to sex. Figure S7. Association of HDL cholesterol levels with risk of eight major cancer forms in women from the Copenhagen General Population Study. Figure S8. Association of HDL cholesterol levels with risk of seven major cancer forms in men from the Copenhagen General Population Study. Figure S9. Association of low versus high HDL cholesterol levels with risk of any cancer in individuals from the Copenhagen General Population Study according to covariates. Figure S10. Association of HDL cholesterol and apolipoprotein A1 levels with risk of any cancer and nine major cancer forms in individuals from the Copenhagen General Population Study with all-cause mortality and emigration as competing events. Figure S11. Association of HDL cholesterol and apolipoprotein A1 levels with risk of any cancer in individuals from the Copenhagen General Population Study excluding individuals with 1, 2, and 3 years of follow-up. Figure S12. Association of HDL cholesterol levels with risk of hematological, breast, and respiratory cancer in individuals from the Copenhagen General Population Study excluding individuals with 1, 2, and 3 years of follow-up. Figure S13. Association of apolipoprotein A1 levels with risk of hematological, breast, and respiratory cancer in individuals from the Copenhagen General Population Study excluding individuals with 1, 2, and 3 years of follow-up. Figure S14. HDL cholesterol and apolipoprotein A1 levels adjusted risk of any cancer in individuals from the Copenhagen General Population Study.